Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee September 17, 2014

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Otezla New Drug Initial Review Require Prior Approval Prior Approval Required
Hemangeol New Drug Initial Review Require Prior Approval Prior Approval Required
Opsumit New Drug Initial Review Require Prior Approval Prior Approval Required
Orenitram ER New Drug Initial Review Require Prior Approval Prior Approval Required
Mycamine New Drug Initial Review Remove Prior Approval Requirement Prior Approval Requirement Removed
Ambisome New Drug Initial Review Remove Prior Approval Requirement Prior Approval Requirement Removed
Brilinta PDL Appeal Require Prior Approval Prior Approval Required